Braskem S.A.

NYSE:BAK

Chemicals

Basic Materials
$0.86 -11.76%

-$0.40 today

Market cap
$343.37M
Beta
0.67
P/E (TTM)
-0.7
EPS (TTM)
-$11.45
52W Low $2.32High $5.40

Volume 3.32M

Average 2.97M

BAK EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Braskem S.A.NYSE: BAK

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA grows, but more slowly than its trailing trend

Q1 FY2026 EBITDA of R$3.46B rose 6.3% year over year, behind the +2564.8% change in trailing-twelve-month EBITDA. Sequentially, it rose 62.9% from the prior quarter. Over 3 fiscal years it compounded at -57.3% a year.

Context

  • EBITDA amounted to 0.9% of revenue in FY2025, down 2.6 pp from a year earlier.
  • EBITDA increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 1 analysts of R$11.34B (+1696.0%) for the fiscal year ending Dec 2026, a step up from the -76.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
R$3.46B+62.9% QoQ
Last fiscal yearDec 2025
R$631.35M-76.6% YoY
LTMMar 2026
R$6.93B+2564.8% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.3%+184.1%+177.8 pp
1 year-76.6%+1696.0%+1772.6 pp
3-year CAGR-57.3%+134.7%+192.0 pp
5-year CAGR+66.7%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

BRL · from the income statement

Latest · FY2025
631.35M BRL
Year-over-year change
-76.6%
4-year CAGR
-60.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How BAK compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +2564.8% is the highest of 11, against a peer median of +15.6%.
  • EBITDA amounts to 10.4% of revenue for BAK, versus a peer median of 26.0%.
BAK Competitors
EBITDA for BAK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAKBraskem S.A.LTM Mar 2026R$6.93B BRL+2564.8%-57.3%10.4%
WLKPWestlake Chemical Partners LPLTM Mar 2026$466.81M USD+8.6%-1.5%37.8%
UANCVR Partners, LPLTM Mar 2026$235.69M USD+22.6%-19.4%36.6%
RYAMRayonier Advanced Materials Inc.LTM Mar 2026$171.7M USD+23.7%-2.3%12.0%
ECVTEcovyst Inc.LTM Mar 2026$151.69M USD+37.7%-13.1%18.5%
SCLStepan CompanyLTM Mar 2026$139.93M USD-27.5%-10.3%6.0%
REXREX American Resources CorporationLTM Apr 2026$118.71M USD+6.6%+14.2%18.1%
MUXMcEwen Mining Inc.LTM Mar 2026$79M USD+248.7%—33.5%
NAKNorthern Dynasty Minerals Ltd.LTM Mar 2026-CA$38.33M CAD+44.6%——
CNLCollective Mining Ltd.LTM Mar 2026-$43.45M USD-12.6%——
ASPIASP Isotopes Inc. Common StockLTM Mar 2026-$170.61M USD-417.3%—633.6%
Peer median (excluding BAK) —+15.6%-6.3%26.0%

Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue105.63B96.52B70.57B77.41B69.33B
Cost of Revenue73.57B85.16B67.55B71.41B67.8B
Gross Profit32.06B11.36B3.02B6B1.53B
Gross Margin30.3%11.8%4.3%7.7%2.2%
Research & Development297M374M383M463M450.96M
Selling, General & Admin4.58B4.87B4.39B4.63B4.68B
Operating Expenses4.88B5.25B4.77B4.99B5.48B
Depreciation & Amortization4.18B4.73B5.21B3.75B4.58B
EBITDA25.33B8.11B3.26B2.7B631.35M
EBITDA Margin24.0%8.4%4.6%3.5%0.9%
Operating Income27.18B6.11B(1.75B)1.01B(3.95B)
Operating Margin25.7%6.3%-2.5%1.3%-5.7%
Interest Income440M1.05B873M1.26B711.74M
Interest Expense3.19B3.33B4.78B5.44B5.82B
Other Income / Expenses(9.22B)(6.07B)(4.44B)(18.75B)1.16B
Income Before Tax17.96B47M(6.19B)(17.73B)(2.79B)
Pre-Tax Margin17.0%0.0%-8.8%-22.9%-4.0%
Income Tax Expense4B868M(1.3B)(5.68B)7.96B
Net Income13.99B(336M)(4.58B)(11.32B)(9.69B)
Net Margin13.2%-0.3%-6.5%-14.6%-14.0%
EPS (Basic)35.12(2.06)(11.50)(28.40)(24.32)
EPS (Diluted)35.08(2.06)(11.50)(28.40)(24.32)
Weighted Avg Shares398.11M398.24M398.35M398.6M398.6M
Weighted Avg Shares (Diluted)398.61M398.6M398.35M398.6M398.6M

Braskem S.A.

NYSE:BAK

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.